What is Biological Dynamics?
Biological Dynamics is a San Diego-based molecular diagnostics firm that has pioneered the ExoVerita Pro platform. This technology automates the isolation of exosomes from complex biofluids, a process that was historically labor-intensive and prone to variability. By simplifying this workflow, the company enables researchers and clinicians to achieve high-purity sample analysis, which is essential for the detection of early-stage cancer and the monitoring of treatment responses. Their market position is defined by a commitment to enhancing global health outcomes through sensitive, non-invasive diagnostic tools that bridge the gap between laboratory research and clinical application.
How much funding has Biological Dynamics raised?
Biological Dynamics has raised a total of $27.1M across 2 funding rounds:
Series C
$26.8M
Debt
$350K
Series C (2015): $26.8M with participation from Heritage Group
Debt (2020): $350K led by PPP
Key Investors in Biological Dynamics
Heritage Group
A strategic investment firm focused on the intersection of healthcare and commercial real estate, providing capital and operational expertise to drive growth in specialized service sectors.
PPP
Public-Private Partnership
What's next for Biological Dynamics?
With the recent influx of capital, Biological Dynamics is well-positioned to accelerate the commercialization of its diagnostic platforms. The strategic focus will likely shift toward expanding clinical validation studies and deepening partnerships within the oncology research community. As the company moves forward, the integration of its exosome isolation technology into standard clinical workflows remains a primary objective. By leveraging its current financial standing, the firm is poised to address the growing demand for high-sensitivity diagnostics, potentially setting a new standard for patient care and therapeutic monitoring in the oncology space.
See full Biological Dynamics company page
